Day Two
- Chris Wade - Founder & Partner, Isomer Capital
- Asaf Horesh - Co-Managing Partner, Vintage Investment Partners
How do you approach and pitch to family offices? What do families look for when evaluating managers? Do family offices seek to learn more about the asset class? How can VCs build a relationship with each family?
- Colette Ballou - Investor, Ballou Capital
- Charlotte Palmer - VP, Venture Capital, Integra Global Advisors
- Sophia Martin - Managing Director, 1st Kind
- Natalie Otwoma - Investor, Sibell Family Office
- Ines Dubreuil - Director, Anne and Claude Berda Foundation
- Andreas Schwarz - Head of Cabinet, Startups, Innovation and Research, European Commission
- Andre de Haes - Founder & CEO, BACKED
Is defence technology currently Europe’s biggest focus? What can we expect from GPs and LPs with so much capital being allocated to this space? What can Europe adopt from America’s successes?
- Anne Sraders - Senior Reporter, Sifted
- Ken Gonzalez - Managing Director, NightDragon
- Erin Hallock - Partner, NATO Innovation Fund
- Adam Niewiński - Managing Partner, OTB Ventures
How are fund structures reshaping private markets, and when should GPs look to alternative solution over traditional exits such as IPOs or strategic sales? How can managers ensure fair valuation, LP alignment, and transparency when using these structures to provide liquidity while retaining high-performing assets?
- Olaf Neubert - Managing Director, TopCap Partners
- Dominik Schwarz - Partner, Verdane
- Dror Glass - Founder & Managing Partner, Israel Secondary Funds
- Leyla Holterud - Partner, Vintage Investment Partners
- Olav Ostin - Managing Partner, TempCap
- Francesco De Liva - CEO & Founder, francesco@kruncher.ai
Discussion group run under Chatham House Rule and closed to press. For VC pre-registration, click here
- Jonathan Hollis - Managing Partner, Mountside Ventures
What has been the result of the recent market surge in AI-driven healthcare delivery solutions? Why is the sector attracting significant capital from family offices? Where has innovation arising in life-sciences and biotech in last few year?
- Paolo Pio - Co-founder and General Partner, Exceptional Ventures
- Shahram Seyedin-Noor - Managing Partner, Civilization Ventures
- Charles Conn - Co-founding Partner, Monograph Capital Partners
- Matt Cooper - Co-founder, Exceptional Ventures
- Roel Bulthuis - Managing Partner, Syncona
Should VCs focus on inherent traits instead of credentials when assessing raw potential? How are AI and data-centric methods impacting founder evaluation and deal flow?
- Roxane Sanguinetti - Founding Partner, Alma Angels
- Michael Tefula - Principal & Head of Product, Ada Ventures
- Janneke Niessen - Partner, CapitalT
- Karen Rudich - CEO & Co-Founder, Sherloc
Why are LPs from Japan focusing on European managers? What is their expectation and how does it differ across the various LPs?
A selection of emerging managers will have the opportunity to pitch their funds to a group of LPs. Emerging managers can visit the booking page to secure a discounted ticket.
Applications are now closed.
These exclusive presentations are only open to pre-registered LPs and run under the Chatham House Rule and closed to press. For LP pre-registration email nisa.pun@informa.com.
- Bjorn Tremmerie - Head of Technology Investments, European Investment Fund (EIF)
- Joe Schorge - Founder and Managing Partner, Isomer Capital
How is ESG data in venture evolving from compliance-driven reporting to decision-useful insight? Hear from LPs and GPs leading efforts to standardise, benchmark and extract long-term value from ESG data across funds and portfolios.
- Henry Philipson - Director of Marketing and Communications, Beringea
- Chris Elphick - Head of Venture Capital, UK Private Capital
- Theresa Bardubitzki - Senior Sustainability Manager, KfW Capital
- Marie Bos - VP,ESG, HV Capital
- Chris Wade - Founder & Partner, Isomer Capital